<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
<channel>
<title>vol. 28, no. 02</title>
<link>http://sedici.unlp.edu.ar:80/handle/10915/221</link>
<description/>
<pubDate>Thu, 19 Nov 2026 15:07:37 GMT</pubDate>
<dc:date>2026-11-19T15:07:37Z</dc:date>
<item>
<title>The studies on hydrophilic-lipophilic balance (HLB): sixty years after William C. Griffin's pioneer work (1949-2009)</title>
<link>http://sedici.unlp.edu.ar:80/handle/10915/7764</link>
<description>Articulo
Latin American Journal of Pharmacy; vol. 28, no. 2
The Hydrophilic-Lipophilic Balance (HLB)was formally presented by William C. Griffin sixty years ago at a meeting in Chicago for the first time and later on in an article published in the first volume of the Journal of the Society of Cosmetic Chemists. In later publications, Griffin proposed formulas&#13;
for the HLB value calculation that are satisfactory for non-ionic surfactants of various types. Several experimental methods developed then in order to obtain the HLB values of surfactants and required HLB of oils in a way simpler than with Griffin's original experimental method. Also there were proposed mathematical equations that HLB values of surfactants allows to calculate from its chemical formulae and also from quality control data of surfactants and its components.
</description>
<pubDate>Thu, 01 Jan 2009 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://sedici.unlp.edu.ar:80/handle/10915/7764</guid>
<dc:date>2009-01-01T00:00:00Z</dc:date>
<dc:description>The Hydrophilic-Lipophilic Balance (HLB)was formally presented by William C. Griffin sixty years ago at a meeting in Chicago for the first time and later on in an article published in the first volume of the Journal of the Society of Cosmetic Chemists. In later publications, Griffin proposed formulas&#13;
for the HLB value calculation that are satisfactory for non-ionic surfactants of various types. Several experimental methods developed then in order to obtain the HLB values of surfactants and required HLB of oils in a way simpler than with Griffin's original experimental method. Also there were proposed mathematical equations that HLB values of surfactants allows to calculate from its chemical formulae and also from quality control data of surfactants and its components.</dc:description>
</item>
<item>
<title>Excipientes co-processados para compressão direta de comprimidos</title>
<link>http://sedici.unlp.edu.ar:80/handle/10915/7763</link>
<description>Articulo
Co-processed excipients for direct compression tablets
Latin American Journal of Pharmacy; vol. 28, no. 2
A presente revisão bibliográfica tem como objetivo delinear o panorama dos adjuvantes para&#13;
compressão direta existentes no mercado denominados de excipientes co-processados. Estes materiais são&#13;
elaborados a partir da combinação de dois ou mais excipientes através de um processamento farmacotécnico&#13;
originando um produto com propriedades funcionais diferenciadas sem provocar, contudo modificações&#13;
químicas nas suas estruturas originais. O desenvolvimento de excipientes co-processados responde a&#13;
recente tendência da fabricação de comprimidos por compressão direta devido as suas vantagens materiais&#13;
e econômicas. Atualmente existe disponíveis no mercado inúmeras variedades de diluentes co-processados,&#13;
como Cellactose®, Starlac®, Ludipress®, MicroceLac® e Prosolv® capazes de melhorar as propriedades&#13;
mecânicas dos princípios ativos viabilizando a compressão direta de fármacos que até então não&#13;
atendiam aos estreitos requisitos deste processo.; The present review aims to outline a panorama of directly compressible adjuvants available in the market named co-processed excipients. These materials are elaborate by combining two or more established excipients through a galenic process producing a unique functional product without chemical changes. The development of co-processed excipients has been carried out in consequence of the recent tendency of tablets manufacture by direct compression owing to its materials and economic advantages. Currently, exist available in the market several sorts of co-processed adjuvants, such as Cellactose®, Starlac®, Ludipress®, MicroceLac® and Prosolv®. These co-processed products are able to improve mechanical properties of active ingredients and make possible a direct compression of drugs that until now do not satisfy the exigencies of this process.
</description>
<pubDate>Thu, 01 Jan 2009 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://sedici.unlp.edu.ar:80/handle/10915/7763</guid>
<dc:date>2009-01-01T00:00:00Z</dc:date>
<dc:description>A presente revisão bibliográfica tem como objetivo delinear o panorama dos adjuvantes para&#13;
compressão direta existentes no mercado denominados de excipientes co-processados. Estes materiais são&#13;
elaborados a partir da combinação de dois ou mais excipientes através de um processamento farmacotécnico&#13;
originando um produto com propriedades funcionais diferenciadas sem provocar, contudo modificações&#13;
químicas nas suas estruturas originais. O desenvolvimento de excipientes co-processados responde a&#13;
recente tendência da fabricação de comprimidos por compressão direta devido as suas vantagens materiais&#13;
e econômicas. Atualmente existe disponíveis no mercado inúmeras variedades de diluentes co-processados,&#13;
como Cellactose®, Starlac®, Ludipress®, MicroceLac® e Prosolv® capazes de melhorar as propriedades&#13;
mecânicas dos princípios ativos viabilizando a compressão direta de fármacos que até então não&#13;
atendiam aos estreitos requisitos deste processo.

The present review aims to outline a panorama of directly compressible adjuvants available in the market named co-processed excipients. These materials are elaborate by combining two or more established excipients through a galenic process producing a unique functional product without chemical changes. The development of co-processed excipients has been carried out in consequence of the recent tendency of tablets manufacture by direct compression owing to its materials and economic advantages. Currently, exist available in the market several sorts of co-processed adjuvants, such as Cellactose®, Starlac®, Ludipress®, MicroceLac® and Prosolv®. These co-processed products are able to improve mechanical properties of active ingredients and make possible a direct compression of drugs that until now do not satisfy the exigencies of this process.</dc:description>
</item>
<item>
<title>Present and future of the radio-molecules used in detection of sentinel lymphatic nodes</title>
<link>http://sedici.unlp.edu.ar:80/handle/10915/7762</link>
<description>Articulo
Latin American Journal of Pharmacy; vol. 28, no. 2
Detection of the sentinel lymph node has become a mainstay of certain surgical interventions for cancer. In this sense, physiological and biochemical properties of the molecules employed for early detection of such metastasis have become relevant in many specialties. Traditionally the main characteristics considered for such radiopharmaceuticals are particle size and surface features. In addition, design of radiolabeled molecules has to take in account anatomy of the vascular lymphatic epithelium and its interaction with such agents. The aim is to create more specific and effective drugs, thus precisely shaping and eventually remodelling the surgical strategy for a given patient. Advances in diagnostic imaging open perspectives for additional categories of agents, endowed with different physico-chemical features as required&#13;
by positron-emission tomography and other sophisticated procedures. This review covers the molecules used in sentinel node finding as well as some related topics, which can help to understand their action mechanism and failures.
</description>
<pubDate>Thu, 01 Jan 2009 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://sedici.unlp.edu.ar:80/handle/10915/7762</guid>
<dc:date>2009-01-01T00:00:00Z</dc:date>
<dc:description>Detection of the sentinel lymph node has become a mainstay of certain surgical interventions for cancer. In this sense, physiological and biochemical properties of the molecules employed for early detection of such metastasis have become relevant in many specialties. Traditionally the main characteristics considered for such radiopharmaceuticals are particle size and surface features. In addition, design of radiolabeled molecules has to take in account anatomy of the vascular lymphatic epithelium and its interaction with such agents. The aim is to create more specific and effective drugs, thus precisely shaping and eventually remodelling the surgical strategy for a given patient. Advances in diagnostic imaging open perspectives for additional categories of agents, endowed with different physico-chemical features as required&#13;
by positron-emission tomography and other sophisticated procedures. This review covers the molecules used in sentinel node finding as well as some related topics, which can help to understand their action mechanism and failures.</dc:description>
</item>
<item>
<title>Antibacterial activity of the crude ethanol extract from jacaranda decurrens leaves</title>
<link>http://sedici.unlp.edu.ar:80/handle/10915/7761</link>
<description>Articulo
Latin American Journal of Pharmacy; vol. 28, no. 2
This study evaluated the antimicrobial activity of the leaves crude ethanol extract of Jacaranda decurrens Cham. (Bignoniaceae). The crude ethanol extract was obtained from the material collected in Senador Canedo and Mossâmedes, Goiás, Brazil, pulverized and submitted to phytochemical&#13;
screening. The antimicrobial activity was evaluated against Gram-positive and Gram-negative bacteria using the well diffusion test and the agar dilution method for determining the minimum inhibitory concentration (MIC). The phytochemical screening showed the presence of flavonoid heterosides and coumarins. The crude ethanol extract demonstrated antimicrobial activity against all microorganisms tested. The&#13;
MIC of J. decurrens for the Gram-positive bacteria varied from 2.18 mg/mL to 8.75 mg/mL. The MIC for the Gram-negative bacteria was 17.5 mg/mL except for Pseudomonas aeruginosa (MIC = 8.75 mg/mL) and Serratia marcescens (MIC = 35 mg/mL). This was the first report of antimicrobial activity of J. decurrens.
</description>
<pubDate>Thu, 01 Jan 2009 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://sedici.unlp.edu.ar:80/handle/10915/7761</guid>
<dc:date>2009-01-01T00:00:00Z</dc:date>
<dc:description>This study evaluated the antimicrobial activity of the leaves crude ethanol extract of Jacaranda decurrens Cham. (Bignoniaceae). The crude ethanol extract was obtained from the material collected in Senador Canedo and Mossâmedes, Goiás, Brazil, pulverized and submitted to phytochemical&#13;
screening. The antimicrobial activity was evaluated against Gram-positive and Gram-negative bacteria using the well diffusion test and the agar dilution method for determining the minimum inhibitory concentration (MIC). The phytochemical screening showed the presence of flavonoid heterosides and coumarins. The crude ethanol extract demonstrated antimicrobial activity against all microorganisms tested. The&#13;
MIC of J. decurrens for the Gram-positive bacteria varied from 2.18 mg/mL to 8.75 mg/mL. The MIC for the Gram-negative bacteria was 17.5 mg/mL except for Pseudomonas aeruginosa (MIC = 8.75 mg/mL) and Serratia marcescens (MIC = 35 mg/mL). This was the first report of antimicrobial activity of J. decurrens.</dc:description>
</item>
<item>
<title>Simple high performance liquid chromatography method for determination of benzalkonium chloride homologues in nasal preparations</title>
<link>http://sedici.unlp.edu.ar:80/handle/10915/7760</link>
<description>Articulo
Latin American Journal of Pharmacy; vol. 28, no. 2
A High-Performance Liquid Chromatography method was developed for quantification of benzalkonium chloride (BAC) and separation of three major homologues, in nasal preparations. Chromatography separation was carried out on a CLC-cyano column, using 0.075M acetate buffer with acetonitrile (45:55, v/v) pH = 5.0, as mobile phase, in an isocratic elution. The total run time was 20 min at a flow rate of 1.0 mL/min. The retention times were of 10.0, 12.8 and 16.1 min, respectively, for homologs C12 , C14 and C16 of benzalkonium chloride. About precision, the method presented excellent repeatability and satisfactory precision intermediate, and the coefficients of variation found were 1.73 and 4.51%, respectively. The accuracy values were ranging from 100.86 to 110.99%. The lower limits of quantification and detection were 5 μg/mL and 2.5 μg/mL, respectively. Two out of seven analyzed lots contained less BAC than allowed.
</description>
<pubDate>Thu, 01 Jan 2009 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://sedici.unlp.edu.ar:80/handle/10915/7760</guid>
<dc:date>2009-01-01T00:00:00Z</dc:date>
<dc:description>A High-Performance Liquid Chromatography method was developed for quantification of benzalkonium chloride (BAC) and separation of three major homologues, in nasal preparations. Chromatography separation was carried out on a CLC-cyano column, using 0.075M acetate buffer with acetonitrile (45:55, v/v) pH = 5.0, as mobile phase, in an isocratic elution. The total run time was 20 min at a flow rate of 1.0 mL/min. The retention times were of 10.0, 12.8 and 16.1 min, respectively, for homologs C12 , C14 and C16 of benzalkonium chloride. About precision, the method presented excellent repeatability and satisfactory precision intermediate, and the coefficients of variation found were 1.73 and 4.51%, respectively. The accuracy values were ranging from 100.86 to 110.99%. The lower limits of quantification and detection were 5 μg/mL and 2.5 μg/mL, respectively. Two out of seven analyzed lots contained less BAC than allowed.</dc:description>
</item>
<item>
<title>Free radical scavenginga activity and flavonoids contents of Polygonum orientale leaf, stem and seed extracts</title>
<link>http://sedici.unlp.edu.ar:80/handle/10915/7759</link>
<description>Articulo
Latin American Journal of Pharmacy; vol. 28, no. 2
The present study was designed to explore the total flavonoid and taxifolin contents and the radical scavenging activity of 50% ethanol extracts of Polygonum orientale leaf, stem and seed by 2,2- diphenyl-1-picrylhydrazyl (DPPH) assay. The extract with higher total flavonoid content has higher radical scavenging activity. Taxifolin (IC50 = 2.83 μmol/L) has stronger antioxidant activity than that of rutin (IC50 = 3.08 μmol/L). The free radical scavenging potential of the chloroform, ethyl acetate, water, ethanol and methanol extracts of P. orientale seed were also investigated. The free radical scavenging abilities of various extracts were determined as: methanol &gt; ethanol &gt; water &gt; ethyl acetate &gt; chloroform
</description>
<pubDate>Thu, 01 Jan 2009 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://sedici.unlp.edu.ar:80/handle/10915/7759</guid>
<dc:date>2009-01-01T00:00:00Z</dc:date>
<dc:description>The present study was designed to explore the total flavonoid and taxifolin contents and the radical scavenging activity of 50% ethanol extracts of Polygonum orientale leaf, stem and seed by 2,2- diphenyl-1-picrylhydrazyl (DPPH) assay. The extract with higher total flavonoid content has higher radical scavenging activity. Taxifolin (IC50 = 2.83 μmol/L) has stronger antioxidant activity than that of rutin (IC50 = 3.08 μmol/L). The free radical scavenging potential of the chloroform, ethyl acetate, water, ethanol and methanol extracts of P. orientale seed were also investigated. The free radical scavenging abilities of various extracts were determined as: methanol &gt; ethanol &gt; water &gt; ethyl acetate &gt; chloroform</dc:description>
</item>
<item>
<title>Diphenylpropanoids from quisqualis indica linn. and their anti-staphylococcal activity</title>
<link>http://sedici.unlp.edu.ar:80/handle/10915/7758</link>
<description>Articulo
Latin American Journal of Pharmacy; vol. 28, no. 2
Four diphenylpropanoids- 1-(4-hydroxy-3-methoxyphenyl)-2-(4-allyl-2,6-dimethoxyphenoxy)propan-1-ol (1), 1-(3,4-dimethoxyphenyl)-2-(4-allyl-2,6-dimethoxyphenoxy)propan-1-ol (2), 1-(3,4- dime thoxyphenyl ) -2- (4-al lyl -2,6-dime thoxyphenoxy)propan-1-ylac e tat e (3) and 1- (4-hydroxy-3,5- dimethoxyphenyl)-2-(4-allyl-2,6-dimethoxyphenoxy) propan-1-ol (4) were isolated from the chloroform soluble fraction of a methanol extract of Quisqualis indica. The structures of these compounds were established unambiguously by MS and a series of 1D and 2D-NMR analyses. All compounds were tested for their anti-staphylococcal activity against a total of five multidrug-resistant (MDR) and methicillin-resistant Staphylococcus aureus strains and the minimum inhibitory concentrations (MICs) were in the range of 128-256 μg/ml
</description>
<pubDate>Thu, 01 Jan 2009 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://sedici.unlp.edu.ar:80/handle/10915/7758</guid>
<dc:date>2009-01-01T00:00:00Z</dc:date>
<dc:description>Four diphenylpropanoids- 1-(4-hydroxy-3-methoxyphenyl)-2-(4-allyl-2,6-dimethoxyphenoxy)propan-1-ol (1), 1-(3,4-dimethoxyphenyl)-2-(4-allyl-2,6-dimethoxyphenoxy)propan-1-ol (2), 1-(3,4- dime thoxyphenyl ) -2- (4-al lyl -2,6-dime thoxyphenoxy)propan-1-ylac e tat e (3) and 1- (4-hydroxy-3,5- dimethoxyphenyl)-2-(4-allyl-2,6-dimethoxyphenoxy) propan-1-ol (4) were isolated from the chloroform soluble fraction of a methanol extract of Quisqualis indica. The structures of these compounds were established unambiguously by MS and a series of 1D and 2D-NMR analyses. All compounds were tested for their anti-staphylococcal activity against a total of five multidrug-resistant (MDR) and methicillin-resistant Staphylococcus aureus strains and the minimum inhibitory concentrations (MICs) were in the range of 128-256 μg/ml</dc:description>
</item>
<item>
<title>Actividad antiinflamatoria local de &lt;i&gt;Malva sylvestris&lt;/i&gt; L. (Malvaceae) en el edema inducido por carragenina en ratas</title>
<link>http://sedici.unlp.edu.ar:80/handle/10915/7757</link>
<description>Articulo
Topical antiinflammatory activity of &lt;i&gt;Malva sylvestris&lt;/i&gt; L. (Malvaceae) on carragenin-induced edema in rats
Latin American Journal of Pharmacy; vol. 28, no. 2
La malva (Malva sylvestris L., Malvaceae) es una planta medicinal ampliamente utilizada en aplicación tópica como demulcente, cicatrizante, anti-hemorroidal, para mucosas o piel. Sin embargo su actividad antiinflamatoria tópica no ha sido reportada en ensayos preclínicos ni clínicos. En este trabajo se estudió el efecto inhibidor del edema inducido por carragenina en ratas de una crema con extracto de malva al 5, 10 y 20%. Se obtuvo una inhibición significativa del edema con la crema de malva al 5% respecto de la crema placebo, y el efecto fue superior al obtenido por la aplicación tópica de crema de indometacina al 2%. Los resultados confirman la actividad antiinflamatoria tópica del extracto de malva en piel, y avalan la indicación de esta planta medicinal en la inflamación local.; Malva (Malva sylvestris L., Malvaceae) is a medicinal plant frequently used in topical application as a demulcent, healing, anti-hemorroidal, for skin and mucus. Nevertheless, its topical anti-inflammatory effect has never been demonstrated by preclinical nor clinical tests. In this work, the effects of a 5, 10 and 20% of malva extract cream on the carragenin-induced edema in rats were studied. A significative inhibition of edema was obtained with the 5% malva cream regarding the placebo, and the effect of malva was higher than that of a 2% indometacin cream. The results give support to the topical antiinflammatory effect of malva on the skin, and to the indication of this plant in local inflammation.
</description>
<pubDate>Thu, 01 Jan 2009 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://sedici.unlp.edu.ar:80/handle/10915/7757</guid>
<dc:date>2009-01-01T00:00:00Z</dc:date>
<dc:description>La malva (Malva sylvestris L., Malvaceae) es una planta medicinal ampliamente utilizada en aplicación tópica como demulcente, cicatrizante, anti-hemorroidal, para mucosas o piel. Sin embargo su actividad antiinflamatoria tópica no ha sido reportada en ensayos preclínicos ni clínicos. En este trabajo se estudió el efecto inhibidor del edema inducido por carragenina en ratas de una crema con extracto de malva al 5, 10 y 20%. Se obtuvo una inhibición significativa del edema con la crema de malva al 5% respecto de la crema placebo, y el efecto fue superior al obtenido por la aplicación tópica de crema de indometacina al 2%. Los resultados confirman la actividad antiinflamatoria tópica del extracto de malva en piel, y avalan la indicación de esta planta medicinal en la inflamación local.

Malva (Malva sylvestris L., Malvaceae) is a medicinal plant frequently used in topical application as a demulcent, healing, anti-hemorroidal, for skin and mucus. Nevertheless, its topical anti-inflammatory effect has never been demonstrated by preclinical nor clinical tests. In this work, the effects of a 5, 10 and 20% of malva extract cream on the carragenin-induced edema in rats were studied. A significative inhibition of edema was obtained with the 5% malva cream regarding the placebo, and the effect of malva was higher than that of a 2% indometacin cream. The results give support to the topical antiinflammatory effect of malva on the skin, and to the indication of this plant in local inflammation.</dc:description>
</item>
<item>
<title>Estudo fitoquímico e avaliação da atividade antimicrobiana de Talauma ovata (Magnoliaceae)</title>
<link>http://sedici.unlp.edu.ar:80/handle/10915/7756</link>
<description>Articulo
Phytochemical study and antimicrobial activity evaluation of Talauma ovata
Latin American Journal of Pharmacy; vol. 28, no. 2
O estudo fitoquímico de cascas do tronco e folhas de Talauma ovata St. Hil. (Magnoliaceae) levou ao isolamento das lactonas sesquiterpênicas costunolídeo e partenolídeo e dos alcalóides aporfínicos liriodenina, lanuginosina, dicentrinona, O-metilmoschatolina e N-acetilxilopina. Os extratos brutos, frações de extratos obtidas por partição com solventes e substâncias isoladas foram avaliadas pelo método de difusão em ágar, utilizando-se 15 bactérias Gram-positivas, 3 bactérias Gram-negativas e 3 fungos. A maior atividade foi detectada na fração em diclorometano do extrato em etanol das cascas, a qual foi ativa contra bactérias Gram-positivas. Nenhum extrato ou fração inibiu o crescimento de bactérias Gram-negativas ou fungos. Partenolídeo e O-metilmoschatolina apresentaram boa atividade contra várias cepas de Staphylococcus aureus, com concentração inibitória mínima (CIM) variando entre 100 e 25 μg/mL. O alcalóide Nacetilxilopina apresentou moderada atividade antifúngica (CIM = 250 μg/mL). Liriodenina, lanuginosina, dicentrinona e O-metilmoschatolina estão sendo descritos pela primeira vez nesta espécie.; Petroleum ether and ethanol extracts of trunk bark and leaves from Talauma ovata St. Hil. (Magnoliaceae) were submitted to chromatographic separation. This procedure furnished the sesquiterpene lactones costunolide and parthenolide and the aporphine alkaloids liriodenine, lanuginosine, dicentrinone, O-methylmoschatoline and N-acetylxylopine. Crude extracts, fractions from sequential partition with solvents and isolated compounds were screened against 15 Gram-positive bacteria, 3 Gram-negative bacteria and 3 yeasts, using the agar well-diffusion technique. The most activity was detected in the fraction in dichloromethane from ethanol extract of trunk bark, which was active against Gram-positive bacteria, but not against Gram-negative bacteria or fungi. Parthenolide and O-methylmoschatoline showed good and specific activity against several strains of Staphylococcus aureus, with minimum inhibitory concentration (MIC) varying from 100 to 25 μg/mL. The alkaloid N-acetylxylopine exhibited moderate activity against Candida albicans (MIC = 250 μg/mL). This is the first report of liriodenine, lanuginosine, dicentrinone and O-methylmoschatoline in T. ovata
</description>
<pubDate>Thu, 01 Jan 2009 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://sedici.unlp.edu.ar:80/handle/10915/7756</guid>
<dc:date>2009-01-01T00:00:00Z</dc:date>
<dc:description>O estudo fitoquímico de cascas do tronco e folhas de Talauma ovata St. Hil. (Magnoliaceae) levou ao isolamento das lactonas sesquiterpênicas costunolídeo e partenolídeo e dos alcalóides aporfínicos liriodenina, lanuginosina, dicentrinona, O-metilmoschatolina e N-acetilxilopina. Os extratos brutos, frações de extratos obtidas por partição com solventes e substâncias isoladas foram avaliadas pelo método de difusão em ágar, utilizando-se 15 bactérias Gram-positivas, 3 bactérias Gram-negativas e 3 fungos. A maior atividade foi detectada na fração em diclorometano do extrato em etanol das cascas, a qual foi ativa contra bactérias Gram-positivas. Nenhum extrato ou fração inibiu o crescimento de bactérias Gram-negativas ou fungos. Partenolídeo e O-metilmoschatolina apresentaram boa atividade contra várias cepas de Staphylococcus aureus, com concentração inibitória mínima (CIM) variando entre 100 e 25 μg/mL. O alcalóide Nacetilxilopina apresentou moderada atividade antifúngica (CIM = 250 μg/mL). Liriodenina, lanuginosina, dicentrinona e O-metilmoschatolina estão sendo descritos pela primeira vez nesta espécie.

Petroleum ether and ethanol extracts of trunk bark and leaves from Talauma ovata St. Hil. (Magnoliaceae) were submitted to chromatographic separation. This procedure furnished the sesquiterpene lactones costunolide and parthenolide and the aporphine alkaloids liriodenine, lanuginosine, dicentrinone, O-methylmoschatoline and N-acetylxylopine. Crude extracts, fractions from sequential partition with solvents and isolated compounds were screened against 15 Gram-positive bacteria, 3 Gram-negative bacteria and 3 yeasts, using the agar well-diffusion technique. The most activity was detected in the fraction in dichloromethane from ethanol extract of trunk bark, which was active against Gram-positive bacteria, but not against Gram-negative bacteria or fungi. Parthenolide and O-methylmoschatoline showed good and specific activity against several strains of Staphylococcus aureus, with minimum inhibitory concentration (MIC) varying from 100 to 25 μg/mL. The alkaloid N-acetylxylopine exhibited moderate activity against Candida albicans (MIC = 250 μg/mL). This is the first report of liriodenine, lanuginosine, dicentrinone and O-methylmoschatoline in T. ovata</dc:description>
</item>
<item>
<title>UV-Derivative spectrophotometric and stability-indicating high-performance liquid chromatographic methods for determination of Simvastatin in tablets</title>
<link>http://sedici.unlp.edu.ar:80/handle/10915/7755</link>
<description>Articulo
Latin American Journal of Pharmacy; vol. 28, no. 2
A stability-indicating high-performance liquid chromatographic (HPLC) and a second-order derivative spectrophotometric (UVDS) analytical methods were validated and compared for determination of simvastatin in tablets. The HPLC method was performed with isocratic elution using a C18 column and a mobile phase composed of methanol:acetonitrile:water (60:20:20, v/v/v) at a flow rate of 1.0 ml/min. The detection was made at 239 nm. In UVDS method, methanol and water were used in first dilution and distilled water was used in consecutive dilutions and as background. The second-order derivative signal measurement was taken at 255 nm. Analytical curves showed correlation coefficients &gt; 0.999 for both methods. The quantitation limits (QL) were 2.41 μg/ml for HPLC and 0.45 μg/ml for UVDS, respectively. Intra and inter-day relative standard deviations were &lt; 2.0 %. Statistical analysis with t- and F-tests are not exceeding their critical values demonstrating that there is no significant difference between the two methods at 95 % confidence level.
</description>
<pubDate>Thu, 01 Jan 2009 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://sedici.unlp.edu.ar:80/handle/10915/7755</guid>
<dc:date>2009-01-01T00:00:00Z</dc:date>
<dc:description>A stability-indicating high-performance liquid chromatographic (HPLC) and a second-order derivative spectrophotometric (UVDS) analytical methods were validated and compared for determination of simvastatin in tablets. The HPLC method was performed with isocratic elution using a C18 column and a mobile phase composed of methanol:acetonitrile:water (60:20:20, v/v/v) at a flow rate of 1.0 ml/min. The detection was made at 239 nm. In UVDS method, methanol and water were used in first dilution and distilled water was used in consecutive dilutions and as background. The second-order derivative signal measurement was taken at 255 nm. Analytical curves showed correlation coefficients &gt; 0.999 for both methods. The quantitation limits (QL) were 2.41 μg/ml for HPLC and 0.45 μg/ml for UVDS, respectively. Intra and inter-day relative standard deviations were &lt; 2.0 %. Statistical analysis with t- and F-tests are not exceeding their critical values demonstrating that there is no significant difference between the two methods at 95 % confidence level.</dc:description>
</item>
<item>
<title>Preparation and in vitro and in vivo evaluation of glipizide mucoadhesive microspheres using factorial design</title>
<link>http://sedici.unlp.edu.ar:80/handle/10915/7754</link>
<description>Articulo
Latin American Journal of Pharmacy; vol. 28, no. 2
The purpose of the research was to prepare controlled release glipizide mucoadhesive microspheres with a coat consisting of sodium alginate and a mucoadhesive polymer Carbopol 971P. Orificeionic gelation method by using 3&lt;sup&gt;2&lt;/sup&gt; factorial design were investigated with a view to develop mucoadhesive microspheres of controlled release. The resulting microspheres were discrete, free flowing, spherical and multinucleate monolithic type. Microencapsulation efficiency was in the range of 56-88%. Microspheres exhibit good mucoadhesive property in the falling film test. Glipizide release from the mucoadhesive microspheres was slow and extended over long period of time. Drug release was non-Fickian type. The concentration of carbopol 971P and sodium alginate had a more significant effect on different variables. In-vivo testing demonstrated a significant hypoglycemic effect of glipizide
</description>
<pubDate>Thu, 01 Jan 2009 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://sedici.unlp.edu.ar:80/handle/10915/7754</guid>
<dc:date>2009-01-01T00:00:00Z</dc:date>
<dc:description>The purpose of the research was to prepare controlled release glipizide mucoadhesive microspheres with a coat consisting of sodium alginate and a mucoadhesive polymer Carbopol 971P. Orificeionic gelation method by using 3&lt;sup&gt;2&lt;/sup&gt; factorial design were investigated with a view to develop mucoadhesive microspheres of controlled release. The resulting microspheres were discrete, free flowing, spherical and multinucleate monolithic type. Microencapsulation efficiency was in the range of 56-88%. Microspheres exhibit good mucoadhesive property in the falling film test. Glipizide release from the mucoadhesive microspheres was slow and extended over long period of time. Drug release was non-Fickian type. The concentration of carbopol 971P and sodium alginate had a more significant effect on different variables. In-vivo testing demonstrated a significant hypoglycemic effect of glipizide</dc:description>
</item>
<item>
<title>Determination of phenytoin in human plasma by a validated liquid chromatography method and its application to a bioequivalence study</title>
<link>http://sedici.unlp.edu.ar:80/handle/10915/7753</link>
<description>Articulo
Latin American Journal of Pharmacy; vol. 28, no. 2
A sensitive and specific method based on liquid chromatography was developed and validated for the determination of phenytoin in human plasma using phenobarbital as internal standard. The drugs were extracted from plasma by liquid-liquid extraction and separated isocratically on a Phenomenex  Synergi MAX-RP C&lt;sub&gt;12&lt;/sub&gt; column (150x 4.6 mm i.d.), with water: acetonitrile: methanol(58.8:15.2:26, v/v/v) as mobile phase. Detection was carried out using photodiode array detector set at 205 nm. The chromatographic separation was obtained within 12 min and was linear in the concentration range of 50-2500 ng/mL (r2 = 0.9999). The method was successfully applied for the bioequivalence study of two tablet formulations (test and reference) of phenytoin 100 mg after single oral dose administration to 28 healthy human volunteers. The 90% confidence intervals were calculated for the C&lt;sub&gt;max&lt;/sub&gt;, AUC&lt;sub&gt;(0-t)&lt;/sub&gt; and AUC&lt;sub&gt;(0-∞)&lt;/sub&gt;, giving values between 99.97–118.40% demonstrating the bioequivalence of the two formulations.
</description>
<pubDate>Thu, 01 Jan 2009 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://sedici.unlp.edu.ar:80/handle/10915/7753</guid>
<dc:date>2009-01-01T00:00:00Z</dc:date>
<dc:description>A sensitive and specific method based on liquid chromatography was developed and validated for the determination of phenytoin in human plasma using phenobarbital as internal standard. The drugs were extracted from plasma by liquid-liquid extraction and separated isocratically on a Phenomenex  Synergi MAX-RP C&lt;sub&gt;12&lt;/sub&gt; column (150x 4.6 mm i.d.), with water: acetonitrile: methanol(58.8:15.2:26, v/v/v) as mobile phase. Detection was carried out using photodiode array detector set at 205 nm. The chromatographic separation was obtained within 12 min and was linear in the concentration range of 50-2500 ng/mL (r2 = 0.9999). The method was successfully applied for the bioequivalence study of two tablet formulations (test and reference) of phenytoin 100 mg after single oral dose administration to 28 healthy human volunteers. The 90% confidence intervals were calculated for the C&lt;sub&gt;max&lt;/sub&gt;, AUC&lt;sub&gt;(0-t)&lt;/sub&gt; and AUC&lt;sub&gt;(0-∞)&lt;/sub&gt;, giving values between 99.97–118.40% demonstrating the bioequivalence of the two formulations.</dc:description>
</item>
<item>
<title>Atividade farmacológica e teor de quercetina de Mirabilis jalapa L.</title>
<link>http://sedici.unlp.edu.ar:80/handle/10915/7752</link>
<description>Articulo
Pharmacology activity and quercetin content of Mirabilis jalapa L.
Latin American Journal of Pharmacy; vol. 28, no. 2
Mirabilis jalapa (Nyctaginaceae), conhecida popularmente em Brasil como "bonina" ou "maravilha", é utilizada popularmente para o tratamento de infecções, inflamações e dores. O extrato bruto etanólico (70%) foi preparado por maceração e fracionado com solventes orgânicos de polaridade crescente (hexano, diclorometano, acetato de etila e butanol). As melhores respostas para a atividade antimicrobiana foram obtidas para Staphylococcus aureus com a fração diclorometano e para Saccharomyces cerevisiae com a fração acetato de etila. Os extratos brutos e frações apresentaram atividade antioxidante pelo método do DPPH, sendo que as frações acetato de etila e butanólica das folhas demonstraram excelente atividade com CI&lt;sub&gt;50&lt;/sub&gt; de 20,40 μg/ml e 25,41 μg/ml, respectivamente. O teor de quercetina (0,19%) foi dosado no extrato das folhas através de cromatografia líquida de alta eficiência. A fração hexânica das folhas apresentou-se altamente tóxica frente a Artemia salina com uma CL50 de 1,27 μg/ml.; Mirabilis jalapa (Nyctaginaceae), popularly known in Brazil as "bonina" or "maravilha", is popularly used to treat infections, inflammations and pains. The crude extract ethanolic (70%) was prepared by maceration and fractionated with organic solvents of increasing polarity (hexane, dichloromethane, ethyl acetate and butanol). The best answer to the antimicrobial activity were obtained for Staphylococcus aureus with the dichloromethane fraction and Saccharomyces cerevisiae with ethyl acetate fraction. The extracts and fractions showed antioxidant activity by the method of DPPH, where the leaf ethyl acetate and butanol fractions showed excellent antioxidant activity with IC&lt;sub&gt;50&lt;/sub&gt; of 20.40 μg/ml and 25.41 μg/ml, respectively. The content of quercetin (0,19%) was determined in extracts from the leaves of liquid chromatography with high efficiency. The leaf hexanic fraction proved to be highly toxic front of Artemia salina with a LC50 of 1.27 μg/ml.
</description>
<pubDate>Thu, 01 Jan 2009 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://sedici.unlp.edu.ar:80/handle/10915/7752</guid>
<dc:date>2009-01-01T00:00:00Z</dc:date>
<dc:description>Mirabilis jalapa (Nyctaginaceae), conhecida popularmente em Brasil como "bonina" ou "maravilha", é utilizada popularmente para o tratamento de infecções, inflamações e dores. O extrato bruto etanólico (70%) foi preparado por maceração e fracionado com solventes orgânicos de polaridade crescente (hexano, diclorometano, acetato de etila e butanol). As melhores respostas para a atividade antimicrobiana foram obtidas para Staphylococcus aureus com a fração diclorometano e para Saccharomyces cerevisiae com a fração acetato de etila. Os extratos brutos e frações apresentaram atividade antioxidante pelo método do DPPH, sendo que as frações acetato de etila e butanólica das folhas demonstraram excelente atividade com CI&lt;sub&gt;50&lt;/sub&gt; de 20,40 μg/ml e 25,41 μg/ml, respectivamente. O teor de quercetina (0,19%) foi dosado no extrato das folhas através de cromatografia líquida de alta eficiência. A fração hexânica das folhas apresentou-se altamente tóxica frente a Artemia salina com uma CL50 de 1,27 μg/ml.

Mirabilis jalapa (Nyctaginaceae), popularly known in Brazil as "bonina" or "maravilha", is popularly used to treat infections, inflammations and pains. The crude extract ethanolic (70%) was prepared by maceration and fractionated with organic solvents of increasing polarity (hexane, dichloromethane, ethyl acetate and butanol). The best answer to the antimicrobial activity were obtained for Staphylococcus aureus with the dichloromethane fraction and Saccharomyces cerevisiae with ethyl acetate fraction. The extracts and fractions showed antioxidant activity by the method of DPPH, where the leaf ethyl acetate and butanol fractions showed excellent antioxidant activity with IC&lt;sub&gt;50&lt;/sub&gt; of 20.40 μg/ml and 25.41 μg/ml, respectively. The content of quercetin (0,19%) was determined in extracts from the leaves of liquid chromatography with high efficiency. The leaf hexanic fraction proved to be highly toxic front of Artemia salina with a LC50 of 1.27 μg/ml.</dc:description>
</item>
<item>
<title>Screening of cytotoxic activity in hexanic and ethanolic extracts of Rollinia laurifolia</title>
<link>http://sedici.unlp.edu.ar:80/handle/10915/7751</link>
<description>Articulo
Latin American Journal of Pharmacy; vol. 28, no. 2
The hexanic and ethanolic extracts obtained from Rollinia laurifolia, collected in Minas Gerais State/Brazil, were screened by the brine shrimp lethality and cytotoxic assays on different cell lines, in order to identify potential sources for novel antitumoral compounds. Fifty percent of the ethanolic derived fractions (E) showed significant cytotoxic activity (IC&lt;sub&gt;50&lt;/sub&gt; &lt; 10–1 μg/mL), not related to tannins or saponins, i. e., IC&lt;sub&gt;50&lt;/sub&gt; E13 on C6 = 1.54 x 10&lt;sup&gt;-2&lt;/sup&gt; μg/mL, IC&lt;sub&gt;50&lt;/sub&gt; E29 on L&lt;sub&gt;929&lt;/sub&gt; and C&lt;sub&gt;6&lt;/sub&gt; = 6.43 x 10&lt;sup&gt;-1&lt;/sup&gt; μg/mL and 3.57 x 10&lt;sup&gt;-2&lt;/sup&gt; μg/mL, respectively. RP-HPLC analysis led to the purification and identification of two known acetogenins, gonionenin and annonin-I, detected for the first time in Rollinia sp, and a new acetogenin, named laurifolin.
</description>
<pubDate>Thu, 01 Jan 2009 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://sedici.unlp.edu.ar:80/handle/10915/7751</guid>
<dc:date>2009-01-01T00:00:00Z</dc:date>
<dc:description>The hexanic and ethanolic extracts obtained from Rollinia laurifolia, collected in Minas Gerais State/Brazil, were screened by the brine shrimp lethality and cytotoxic assays on different cell lines, in order to identify potential sources for novel antitumoral compounds. Fifty percent of the ethanolic derived fractions (E) showed significant cytotoxic activity (IC&lt;sub&gt;50&lt;/sub&gt; &lt; 10–1 μg/mL), not related to tannins or saponins, i. e., IC&lt;sub&gt;50&lt;/sub&gt; E13 on C6 = 1.54 x 10&lt;sup&gt;-2&lt;/sup&gt; μg/mL, IC&lt;sub&gt;50&lt;/sub&gt; E29 on L&lt;sub&gt;929&lt;/sub&gt; and C&lt;sub&gt;6&lt;/sub&gt; = 6.43 x 10&lt;sup&gt;-1&lt;/sup&gt; μg/mL and 3.57 x 10&lt;sup&gt;-2&lt;/sup&gt; μg/mL, respectively. RP-HPLC analysis led to the purification and identification of two known acetogenins, gonionenin and annonin-I, detected for the first time in Rollinia sp, and a new acetogenin, named laurifolin.</dc:description>
</item>
<item>
<title>Investigação preliminar avaliando a influência dos processos de compactação e trituração em relação às propriedades cristalinas e polimórficas da talidomida</title>
<link>http://sedici.unlp.edu.ar:80/handle/10915/7750</link>
<description>Articulo
Preliminary investigation evaluating the influence of compaction and grinding process and relationship with crystalline and polymorphic properties of the thalidomide
Latin American Journal of Pharmacy; vol. 28, no. 2
De acordo com a literatura, sabe-se que a talidomida apresenta formas polimórficas, refletindo em distintos hábitos cristalinos, tamanhos de partícula e velocidades de dissolução intrínseca. Levando-se em consideração esta questão e o fato do medicamento talidomida ser produzido sob a forma farmacêutica comprimidos em alguns países como Brasil, neste trabalho investigou-se a influência dos processos de compactação e trituração em relação à s fases polimórficas de amostras de talidomida. As amostras antes e após serem processadas foram avaliadas por DRX e DSC. A partir dos resultados obtidos por DRX, percebe-se que o efeito da compactação das amostras, adicionado à trituração, resultou em pequena alteração estrutural, embora sem ocorrência de transição polimórfica durante o processo. O polimorfo β apresentou um comportamento cristalográfico diferenciado após o processamento da amostra, sugerindo características compressionais também diferenciadas, as quais poderão ser avaliadas em estudos futuros. Sob altas temperaturas, o polimorfo α sofre transição de fase, convertendo-se ao polimorfo β, sendo esse evento termodinâmico influenciado por características cristalinas particulares a cada amostra, acelerado mediante o processamento das mesmas.; According to literature, thalidomide presents polymorphic forms reflecting in distinct crystalline habits, particle sizes and intrinsic dissolution rates. Taking in account this issue and the fact of thalidomide to be produced as tablets in some countries as Brazil, in this work was investigated the influence of the compaction and grinding process and the relationship with polymorphic phases of thalidomide samples. The samples before and after to be processed were evaluated by XRD and DSC. From the results obtained by XRD is noted that the effect of samples compaction, add to grinding, resulted in small structural change, although without occurrence of polymorphic transition during the process. The β polymorph presented differential crystallographic behavior after processing of the sample, suggesting compressional characteristics also differentiated, which can be evaluated in future studies. Under high temperatures, the α polymorph undergoes phase transition, which becomes converted to the β polymorph, being this thermodynamic event influenced by particular crystalline characteristics of each sample, accelerated by their processing
</description>
<pubDate>Thu, 01 Jan 2009 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://sedici.unlp.edu.ar:80/handle/10915/7750</guid>
<dc:date>2009-01-01T00:00:00Z</dc:date>
<dc:description>De acordo com a literatura, sabe-se que a talidomida apresenta formas polimórficas, refletindo em distintos hábitos cristalinos, tamanhos de partícula e velocidades de dissolução intrínseca. Levando-se em consideração esta questão e o fato do medicamento talidomida ser produzido sob a forma farmacêutica comprimidos em alguns países como Brasil, neste trabalho investigou-se a influência dos processos de compactação e trituração em relação à s fases polimórficas de amostras de talidomida. As amostras antes e após serem processadas foram avaliadas por DRX e DSC. A partir dos resultados obtidos por DRX, percebe-se que o efeito da compactação das amostras, adicionado à trituração, resultou em pequena alteração estrutural, embora sem ocorrência de transição polimórfica durante o processo. O polimorfo β apresentou um comportamento cristalográfico diferenciado após o processamento da amostra, sugerindo características compressionais também diferenciadas, as quais poderão ser avaliadas em estudos futuros. Sob altas temperaturas, o polimorfo α sofre transição de fase, convertendo-se ao polimorfo β, sendo esse evento termodinâmico influenciado por características cristalinas particulares a cada amostra, acelerado mediante o processamento das mesmas.

According to literature, thalidomide presents polymorphic forms reflecting in distinct crystalline habits, particle sizes and intrinsic dissolution rates. Taking in account this issue and the fact of thalidomide to be produced as tablets in some countries as Brazil, in this work was investigated the influence of the compaction and grinding process and the relationship with polymorphic phases of thalidomide samples. The samples before and after to be processed were evaluated by XRD and DSC. From the results obtained by XRD is noted that the effect of samples compaction, add to grinding, resulted in small structural change, although without occurrence of polymorphic transition during the process. The β polymorph presented differential crystallographic behavior after processing of the sample, suggesting compressional characteristics also differentiated, which can be evaluated in future studies. Under high temperatures, the α polymorph undergoes phase transition, which becomes converted to the β polymorph, being this thermodynamic event influenced by particular crystalline characteristics of each sample, accelerated by their processing</dc:description>
</item>
<item>
<title>Dissolution rate enhancement of fenofibrate using liquisolid tablet technique</title>
<link>http://sedici.unlp.edu.ar:80/handle/10915/7749</link>
<description>Articulo
Latin American Journal of Pharmacy; vol. 28, no. 2
Fenofibrate is more effective drug as compared to other fibrates. But low bioavailability of it is due to its poor aqueous solubility. The purpose of present study was to improve fenofibrate dissolution through its formulation into liquisolid tablets and then to investigate in vitro performance of prepared liquisolid systems. By use of this technique, liquid medications such as solutions or suspensions of water insoluble drugs in suitable non-volatile liquid vehicles can be easily converted into powders with acceptable flow properties and compression behavior by using suitable powder excipients. X-ray powder diffraction and Differential Scanning Calorimetry were used for evaluation of physicochemical properties of Fenofibrate in liquisolid tablets. Stereomicroscopy was used to assess morphological characteristics of liquisolid formulation. Enhanced drug release profiles due to increased wetting properties and surface of drug available for dissolution was obtained in case of liquisolid tablets.
</description>
<pubDate>Thu, 01 Jan 2009 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://sedici.unlp.edu.ar:80/handle/10915/7749</guid>
<dc:date>2009-01-01T00:00:00Z</dc:date>
<dc:description>Fenofibrate is more effective drug as compared to other fibrates. But low bioavailability of it is due to its poor aqueous solubility. The purpose of present study was to improve fenofibrate dissolution through its formulation into liquisolid tablets and then to investigate in vitro performance of prepared liquisolid systems. By use of this technique, liquid medications such as solutions or suspensions of water insoluble drugs in suitable non-volatile liquid vehicles can be easily converted into powders with acceptable flow properties and compression behavior by using suitable powder excipients. X-ray powder diffraction and Differential Scanning Calorimetry were used for evaluation of physicochemical properties of Fenofibrate in liquisolid tablets. Stereomicroscopy was used to assess morphological characteristics of liquisolid formulation. Enhanced drug release profiles due to increased wetting properties and surface of drug available for dissolution was obtained in case of liquisolid tablets.</dc:description>
</item>
<item>
<title>Phenobarbital pharmacological findings on the nerve-muscle basis</title>
<link>http://sedici.unlp.edu.ar:80/handle/10915/7748</link>
<description>Articulo
Latin American Journal of Pharmacy; vol. 28, no. 2
Phenobarbital and carbamazepine are antiepileptic drugs that act at the nervous central system by different mechanisms of action. In this work we investigated the pharmacological effects of these drugs on mouse phrenic nerve-diaphragm preparations through the myographic technique. Carbamazepine (0.105, 1.05, 2.1 and 4.2 mM, n = 8, 6, 6 and 6, respectively), induced a dose-dependent neuromuscular blockade, under indirect or direct muscle stimulation and the neurotransmission was reestablished after washing. Conversely, phenobarbital caused an unexpected facilitatory effect, under several formulations, such as the acid-extracted commercial tablets (1.05, 2.1 and 4.2 mM, n = 7, 6 and 7, respectively), commercial phenobarbital solution (4.2 mM, n = 7) or its correspondent pure active ingredient (4.2 and 2.1 mM, n = 6 each). Only at a higher concentration the acid-extracted phenobarbital performed a neuromuscular blockade (8.4 mM, n = 10). The different responses between carbamazepine (paralysis) and phenobarbital (facilitatory effect) evidentiated a new effect for phenobarbital until now concealed at the neuromuscular junction and may involve the glutamatergic regulation, since its role as an acetylcholine co-transmitter in motoneurons was already established.
</description>
<pubDate>Thu, 01 Jan 2009 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://sedici.unlp.edu.ar:80/handle/10915/7748</guid>
<dc:date>2009-01-01T00:00:00Z</dc:date>
<dc:description>Phenobarbital and carbamazepine are antiepileptic drugs that act at the nervous central system by different mechanisms of action. In this work we investigated the pharmacological effects of these drugs on mouse phrenic nerve-diaphragm preparations through the myographic technique. Carbamazepine (0.105, 1.05, 2.1 and 4.2 mM, n = 8, 6, 6 and 6, respectively), induced a dose-dependent neuromuscular blockade, under indirect or direct muscle stimulation and the neurotransmission was reestablished after washing. Conversely, phenobarbital caused an unexpected facilitatory effect, under several formulations, such as the acid-extracted commercial tablets (1.05, 2.1 and 4.2 mM, n = 7, 6 and 7, respectively), commercial phenobarbital solution (4.2 mM, n = 7) or its correspondent pure active ingredient (4.2 and 2.1 mM, n = 6 each). Only at a higher concentration the acid-extracted phenobarbital performed a neuromuscular blockade (8.4 mM, n = 10). The different responses between carbamazepine (paralysis) and phenobarbital (facilitatory effect) evidentiated a new effect for phenobarbital until now concealed at the neuromuscular junction and may involve the glutamatergic regulation, since its role as an acetylcholine co-transmitter in motoneurons was already established.</dc:description>
</item>
<item>
<title>O deficiente visual e a atenção farmacêutica</title>
<link>http://sedici.unlp.edu.ar:80/handle/10915/7747</link>
<description>Articulo
Visual defficient and pharmaceutical care
Latin American Journal of Pharmacy; vol. 28, no. 2
As dificuldades enfrentadas pelos deficientes visuais são inúmeras e uma delas é o uso de medicamentos.&#13;
A grande limitação do acesso à informação sobre produtos farmacêuticos e enfermidades é um&#13;
fato importante que contribui para o uso inadequado de medicamentos. O objetivo deste estudo foi formar&#13;
uma base de dados sobre os deficientes visuais que permita a definição de estratégias para a implantação&#13;
da Atenção Farmacêutica no grupo estudado. O estudo foi realizado entre fevereiro a agosto de 2007 na&#13;
Associação Aliança dos cegos situada na cidade do Rio de Janeiro, Brasil. O termo de consentimento pós&#13;
informado foi obtido de todos participantes antes do início do estudo. A metodologia empregada foi a qualitativa&#13;
em nível exploratório. Os dados foram coletados utilizando-se um roteiro pré definido em 30 participantes&#13;
do sexo masculino com idade entre 18 e 89 anos. A dificuldade de administração de algumas formas&#13;
farmacêuticas foi um dos principais problemas relacionados ao medicamento encontrados no grupo&#13;
estudado. Estratégias foram definidas para a implantação da atenção farmacêutica neste grupo: consulta&#13;
das necessidades, anseios e prioridades dos cegos; comunicação eficiente geradora de confiança e amizade;&#13;
aconselhamento e programas educativos e motivacionais de saúde para os deficientes e sua família; atuação&#13;
de uma equipe multidisciplinar e com visão humanística.; The difficulties faced by visual deficient are countless&#13;
and one of them is the use of medicines. The poor access to the information on pharmaceutical products and diseases&#13;
is a fact that contribute to inadequate use of drugs. The aim of this study was to create data base about special&#13;
needs of visual deficient that allows the definition of strategies to development of the Pharmaceutical Care to&#13;
this group. This study was conducted from February to August 2007 in the visual deficient association called Associação&#13;
Aliança, in the city of Rio de Janeiro, Brazil. Written informed consent was obtained from all participants&#13;
before their enrollment in the study. It was qualitative study in exploratory level. Survey data were collected&#13;
through recorded interviews from thirty male participants aged between 18 to 89 years. The interviews followed&#13;
a subject route previously established. The difficulty of administration of some pharmaceutical forms was&#13;
one of the principal drug-related problems (DRPs) found in this group. Strategies were defined to development&#13;
of the Pharmaceutical Care to this group as follow: evaluation of the needs, expectations and priorities of the visual&#13;
deficient; efficient communication to create trust and friendship; counseling and educational and motivational&#13;
health programs including visual deficients and their family; action of multidisciplinary team with humanistic&#13;
vision.
</description>
<pubDate>Thu, 01 Jan 2009 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://sedici.unlp.edu.ar:80/handle/10915/7747</guid>
<dc:date>2009-01-01T00:00:00Z</dc:date>
<dc:description>As dificuldades enfrentadas pelos deficientes visuais são inúmeras e uma delas é o uso de medicamentos.&#13;
A grande limitação do acesso à informação sobre produtos farmacêuticos e enfermidades é um&#13;
fato importante que contribui para o uso inadequado de medicamentos. O objetivo deste estudo foi formar&#13;
uma base de dados sobre os deficientes visuais que permita a definição de estratégias para a implantação&#13;
da Atenção Farmacêutica no grupo estudado. O estudo foi realizado entre fevereiro a agosto de 2007 na&#13;
Associação Aliança dos cegos situada na cidade do Rio de Janeiro, Brasil. O termo de consentimento pós&#13;
informado foi obtido de todos participantes antes do início do estudo. A metodologia empregada foi a qualitativa&#13;
em nível exploratório. Os dados foram coletados utilizando-se um roteiro pré definido em 30 participantes&#13;
do sexo masculino com idade entre 18 e 89 anos. A dificuldade de administração de algumas formas&#13;
farmacêuticas foi um dos principais problemas relacionados ao medicamento encontrados no grupo&#13;
estudado. Estratégias foram definidas para a implantação da atenção farmacêutica neste grupo: consulta&#13;
das necessidades, anseios e prioridades dos cegos; comunicação eficiente geradora de confiança e amizade;&#13;
aconselhamento e programas educativos e motivacionais de saúde para os deficientes e sua família; atuação&#13;
de uma equipe multidisciplinar e com visão humanística.

The difficulties faced by visual deficient are countless&#13;
and one of them is the use of medicines. The poor access to the information on pharmaceutical products and diseases&#13;
is a fact that contribute to inadequate use of drugs. The aim of this study was to create data base about special&#13;
needs of visual deficient that allows the definition of strategies to development of the Pharmaceutical Care to&#13;
this group. This study was conducted from February to August 2007 in the visual deficient association called Associação&#13;
Aliança, in the city of Rio de Janeiro, Brazil. Written informed consent was obtained from all participants&#13;
before their enrollment in the study. It was qualitative study in exploratory level. Survey data were collected&#13;
through recorded interviews from thirty male participants aged between 18 to 89 years. The interviews followed&#13;
a subject route previously established. The difficulty of administration of some pharmaceutical forms was&#13;
one of the principal drug-related problems (DRPs) found in this group. Strategies were defined to development&#13;
of the Pharmaceutical Care to this group as follow: evaluation of the needs, expectations and priorities of the visual&#13;
deficient; efficient communication to create trust and friendship; counseling and educational and motivational&#13;
health programs including visual deficients and their family; action of multidisciplinary team with humanistic&#13;
vision.</dc:description>
</item>
<item>
<title>Potenciais interferências nos resultados de exames laboratoriais causadas pelo uso de plantas medicinais por pacientes HIV+ e/ou com AIDS</title>
<link>http://sedici.unlp.edu.ar:80/handle/10915/7746</link>
<description>Articulo
Potential interference in laboratory assays due to use of herbal medicines by people living with HIV/Aids
Latin American Journal of Pharmacy; vol. 28, no. 2
As plantas medicinais (PM) podem interferir em exames laboratoriais realizados pelos pacientes&#13;
com HIV/Aids. O objetivo deste estudo foi realizar uma revisão na literatura das potenciais interferências&#13;
nos resultados de exames laboratoriais provocadas pelo uso de plantas medicinais por pacientes HIV+&#13;
e/ou com Aids, em tratamento com anti-retrovirais em Florianópolis, Santa Catarina, Brasil, entre abril e&#13;
setembro de 2008. Dos 200 voluntários entrevistados, a maioria era do sexo masculino (60,5%), da raça&#13;
caucasiana (72,0%), heterossexuais (80,5%), com baixa escolaridade (53,0% não concluíram o ensino médio)&#13;
e com média de idade de 41,5 anos. Do total, 60,5% utilizavam PM no momento da entrevista. As cinco&#13;
PM mais utilizadas foram erva-cidreira (57,0%), hortelã (33,9%), boldo (30,6%), camomila (25,6%) e&#13;
guaco (13,2%). Tais PM podem interferir na determinação sérica de glicose, colesterol, triglicerídeos, ácido&#13;
úrico, marcadores de função hepática e renal e nos testes de coagulação. Este estudo indica a necessidade&#13;
do reconhecimento das potenciais interferências das PM nos exames laboratoriais realizados pelos pacientes&#13;
com HIV/Aids.; Herbal medicines (HM) may interfere with laboratory assays performed on HIV/Aids patients. This&#13;
study aims to review the potential interference in laboratory assays, due to use of HM by people living with&#13;
HIV/Aids and treated in Florianópolis, Santa Catarina, Brazil, between April and September 2008. Of the 200&#13;
volunteers interviewed, the majority were male (60.5%), Caucasian race (72.0%), heterosexual (80.5%), with&#13;
low education (53.0 % have not completed high school) and with an average age of 41.5 years. Of the total, 60.5&#13;
% used HM at the time of the interview. The five most used HM were balm (57.0%), mint (33.9%), bilberry&#13;
(30.6%), chamomile (25.6%) and guaco (13.2%). Such HM may interfere with the serum determination of glucose,&#13;
cholesterol, triglycerides, uric acid, markers of kidney and liver function and coagulation tests. This study&#13;
indicates the need for recognition of the potential interference of the HM in laboratory assays performed by&#13;
HIV/Aids patients.
</description>
<pubDate>Thu, 01 Jan 2009 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://sedici.unlp.edu.ar:80/handle/10915/7746</guid>
<dc:date>2009-01-01T00:00:00Z</dc:date>
<dc:description>As plantas medicinais (PM) podem interferir em exames laboratoriais realizados pelos pacientes&#13;
com HIV/Aids. O objetivo deste estudo foi realizar uma revisão na literatura das potenciais interferências&#13;
nos resultados de exames laboratoriais provocadas pelo uso de plantas medicinais por pacientes HIV+&#13;
e/ou com Aids, em tratamento com anti-retrovirais em Florianópolis, Santa Catarina, Brasil, entre abril e&#13;
setembro de 2008. Dos 200 voluntários entrevistados, a maioria era do sexo masculino (60,5%), da raça&#13;
caucasiana (72,0%), heterossexuais (80,5%), com baixa escolaridade (53,0% não concluíram o ensino médio)&#13;
e com média de idade de 41,5 anos. Do total, 60,5% utilizavam PM no momento da entrevista. As cinco&#13;
PM mais utilizadas foram erva-cidreira (57,0%), hortelã (33,9%), boldo (30,6%), camomila (25,6%) e&#13;
guaco (13,2%). Tais PM podem interferir na determinação sérica de glicose, colesterol, triglicerídeos, ácido&#13;
úrico, marcadores de função hepática e renal e nos testes de coagulação. Este estudo indica a necessidade&#13;
do reconhecimento das potenciais interferências das PM nos exames laboratoriais realizados pelos pacientes&#13;
com HIV/Aids.

Herbal medicines (HM) may interfere with laboratory assays performed on HIV/Aids patients. This&#13;
study aims to review the potential interference in laboratory assays, due to use of HM by people living with&#13;
HIV/Aids and treated in Florianópolis, Santa Catarina, Brazil, between April and September 2008. Of the 200&#13;
volunteers interviewed, the majority were male (60.5%), Caucasian race (72.0%), heterosexual (80.5%), with&#13;
low education (53.0 % have not completed high school) and with an average age of 41.5 years. Of the total, 60.5&#13;
% used HM at the time of the interview. The five most used HM were balm (57.0%), mint (33.9%), bilberry&#13;
(30.6%), chamomile (25.6%) and guaco (13.2%). Such HM may interfere with the serum determination of glucose,&#13;
cholesterol, triglycerides, uric acid, markers of kidney and liver function and coagulation tests. This study&#13;
indicates the need for recognition of the potential interference of the HM in laboratory assays performed by&#13;
HIV/Aids patients.</dc:description>
</item>
<item>
<title>In vivo xylitol primary dermal irritation and phototoxicity evaluation</title>
<link>http://sedici.unlp.edu.ar:80/handle/10915/7745</link>
<description>Articulo
Latin American Journal of Pharmacy; vol. 28, no. 2
Xylitol is a widely studied sugar with therapeutic properties and is effective against microorganisms. Despite a variety of toxicological data being available about this compound, dermal toxicological tests cannot be found. Here, the aim was to carry out in vivo assays to verify xylitol skin application safety.&#13;
Primary dermal irritation studies were done with rabbits using 5 and 10% (w/w) xylitol, in either cream or gel form. Phototoxicity assays were also performed with guinea pigs, using only 10% (w/w) xylitol, in both forms. Primary dermal irritation studies revealed that xylitol topically used (5 and 10%) did not induce erythema or edema formation, but did show phototoxicity properties. Xylitol is an adequate alternative&#13;
compound to be applied for skin disease control, since this application will be done together with sunscreen.
</description>
<pubDate>Thu, 01 Jan 2009 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://sedici.unlp.edu.ar:80/handle/10915/7745</guid>
<dc:date>2009-01-01T00:00:00Z</dc:date>
<dc:description>Xylitol is a widely studied sugar with therapeutic properties and is effective against microorganisms. Despite a variety of toxicological data being available about this compound, dermal toxicological tests cannot be found. Here, the aim was to carry out in vivo assays to verify xylitol skin application safety.&#13;
Primary dermal irritation studies were done with rabbits using 5 and 10% (w/w) xylitol, in either cream or gel form. Phototoxicity assays were also performed with guinea pigs, using only 10% (w/w) xylitol, in both forms. Primary dermal irritation studies revealed that xylitol topically used (5 and 10%) did not induce erythema or edema formation, but did show phototoxicity properties. Xylitol is an adequate alternative&#13;
compound to be applied for skin disease control, since this application will be done together with sunscreen.</dc:description>
</item>
</channel>
</rss>
